Literature DB >> 20634377

Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells.

Alison Y Swaims1, Francesca Khani, Yingyu Zhang, Arthur I Roberts, Satish Devadas, Yufang Shi, Arnold B Rabson.   

Abstract

Infection with the human T-cell leukemia virus-1 (HTLV-1) results in a variety of diseases including adult T-cell leukemia/lymphoma (ATL). Although the pathogenesis of these disorders is poorly understood, it involves complex interactions with the host immune system. Activation of infected T cells may play an important role in disease pathogenesis through induction of the oncogenic HTLV-1 Tax transactivator protein. To test this hypothesis, we employed transgenic mice in which Tax is regulated by the HTLV-1 LTR. T-cell receptor stimulation of LTR-Tax CD4(+) T cells induced Tax expression, hyper-proliferation, and immortalization in culture. The transition to cellular immortalization was accompanied by markedly increased expression of the antiapoptotic gene, mcl-1, previously implicated as important in T-cell survival. Immortalized cells exhibited a CD4(+)CD25(+)CD3(-) phenotype commonly observed in ATL. Engraftment of activated LTR-Tax CD4(+) T cells into NOD/Shi-scid/IL-2Rγ null mice resulted in a leukemia-like phenotype with expansion and tissue infiltration of Tax(+), CD4(+) lymphocytes. We suggest that immune activation of infected CD4(+) T cells plays an important role in the induction of Tax expression, T-cell proliferation, and pathogenesis of ATL in HTLV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634377      PMCID: PMC2974607          DOI: 10.1182/blood-2009-07-231050

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  T-lymphocyte death during shutdown of an immune response.

Authors:  Andreas Strasser; Marc Pellegrini
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

3.  Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors.

Authors:  E M Carvalho; O Bacellar; A F Porto; S Braga; B Galvão-Castro; F Neva
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

4.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

Review 5.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

6.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

Review 8.  The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

Authors:  Arthur I Roberts; Satish Devadas; Xiaoren Zhang; Liying Zhang; Achsah Keegan; Kristy Greeneltch; Jennifer Solomon; Lixin Wei; Jyoti Das; Erwei Sun; Catherine Liu; Zengrong Yuan; Jian-Nian Zhou; Yufang Shi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells.

Authors:  Madeleine Duc Dodon; Zhenlin Li; Samir Hamaia; Louis Gazzolo
Journal:  J Gen Virol       Date:  2004-07       Impact factor: 3.891

10.  Interleukin-13 overexpression by tax transactivation: a potential autocrine stimulus in human T-cell leukemia virus-infected lymphocytes.

Authors:  Katja Wäldele; Grit Schneider; Tobias Ruckes; Ralph Grassmann
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  19 in total

Review 1.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

2.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

3.  Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Authors:  Megan M Romeo; Bookyung Ko; Janice Kim; Rebecca Brady; Hayley C Heatley; Jeffrey He; Carolyn K Harrod; Braden Barnett; Lee Ratner; Michael D Lairmore; Ernest Martinez; Bernhard Lüscher; Craig N Robson; Marie Henriksson; Robert Harrod
Journal:  Virology       Date:  2015-01-05       Impact factor: 3.616

4.  The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis.

Authors:  Megan Romeo; Tetiana Hutchison; Aditi Malu; Averi White; Janice Kim; Rachel Gardner; Katie Smith; Katherine Nelson; Rachel Bergeson; Ryan McKee; Carolyn Harrod; Lee Ratner; Bernhard Lüscher; Ernest Martinez; Robert Harrod
Journal:  Virology       Date:  2018-02-20       Impact factor: 3.616

Review 5.  Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

Authors:  M Matsuoka; K-T Jeang
Journal:  Oncogene       Date:  2010-11-29       Impact factor: 9.867

6.  HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.

Authors:  A Kawatsuki; J-I Yasunaga; Y Mitobe; P L Green; M Matsuoka
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

Review 7.  Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis.

Authors:  Zhaoxia Qu; Gutian Xiao
Journal:  Viruses       Date:  2011-06       Impact factor: 5.048

8.  Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium.

Authors:  Fabiola Martin; Charles R M Bangham; Vincenzo Ciminale; Michael D Lairmore; Edward L Murphy; William M Switzer; Renaud Mahieux
Journal:  Retrovirology       Date:  2011-10-28       Impact factor: 4.602

9.  Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.

Authors:  Nicolas A Gillet; Lucy Cook; Daniel J Laydon; Carol Hlela; Kristien Verdonck; Carolina Alvarez; Eduardo Gotuzzo; Daniel Clark; Lourdes Farré; Achiléa Bittencourt; Becca Asquith; Graham P Taylor; Charles R M Bangham
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

10.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.